Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - vector
17
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
MACHINE LEARNING GUIDED DESIGN OF VIRAL
VECTOR
LIBRARIES
MACHINE LEARNING GUIDED DESIGN OF VIRAL
VECTOR
LIBRARIES Researchers at UC Berkeley have developed a machine learning model that can aide in the design of more efficient viral vector libraries. Directed evolution of biomolecules to generate large numbers of randomized variants is an important innovation in biochemistry. This methodology can be applied...
Published: 8/17/2023
|
Inventor(s):
David Schaffer
,
Jennifer Listgarten
,
Danqing Zhu
,
David Brookes
Keywords(s):
Machine Learning
,
Recombinant Adenoviral-Associated Virus (rAAV)
,
Vector
Category(s):
Technology Classifications > Software
Retroviral
Vector
Packaging Cell Lines and Purification Methods for Gene Therapy
This invention relates to a novel gammaretroviral
vector
packaging cell line and a method of producing gammaretroviral vectors suitable for gene therapy. The described vectors may contain the gibbon ape leukemia virus (GALV) envelope with a CD11D8 epitope tag enabling their purification on a monoclonal antibody conjugated column. These vectors have...
Published: 10/28/2024
|
Inventor(s):
Wenqin Xu
,
Maribeth Eiden
Keywords(s):
Cell
,
Gammaretroviral
,
GB2A2X
,
GB2CXX
,
Genetic
,
Line
,
Listed LPM Maddox as of 4/15/2015
,
Method
,
Novel
,
Packaging
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
Producing
,
Suitable
,
THERAPY
,
Vector
,
vector
s
,
VPXXXX
,
WIXXXX
,
WJXXXX
,
XEXXXX
Category(s):
TherapeuticArea > Cardiology
,
TherapeuticArea > Ophthalmology
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Dental
,
TherapeuticArea > Oncology
,
TherapeuticArea > Endocrinology
,
Application > Research Materials
A Novel Therapeutic
Vector
for Hemoglobin Disorders
Investigators at the National Heart, Lung, and Blood Institute have designed a novel lentiviral
vector
as a potential gene therapy for sickle cell anemia and beta-thalassemia. The novel lentiviral vector encodes the beta-globin gene in a forward orientation and can produce 5-10 fold higher viral titer and 4-10 fold higher gene transfer efficiency to...
Published: 10/28/2024
|
Inventor(s):
John Tisdale
,
Naoya Uchida
Keywords(s):
Development
,
DISORDERS
,
Forward-oriented
,
Generation
,
hemoglobin
,
Listed LPM Maddox as of 4/15/2015
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
therapeutic
,
Therpeutic
,
Vector
,
VPXXXX
,
WJXXXX
,
XEXXXX
,
YAXXXX
,
YBXXXX
,
YCXXXX
Category(s):
Collaboration Sought > Collaboration
,
Application > Therapeutics
,
TherapeuticArea > Endocrinology
,
TherapeuticArea > Dental
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Oncology
A Novel Virus-Based Expression System
The present invention is related to a recombinant viral
vector
for vaccines. Currently available poxvirus vectors for humans and other animals exhibit suboptimal expression of recombinant gene(s) and high expression of vector proteins which causes weak immunogenicity and high anti-vector immune response. The present novel virus-based expression vectors...
Published: 10/28/2024
|
Inventor(s):
Linda Wyatt
,
Bernard Moss
Keywords(s):
Expression
,
Gene
,
GENES
,
High
,
LOW
,
Non-Replicating
,
System
,
TARGET
,
vaccinia
,
Vector
,
virus
,
VJXXXX
,
VKXXXX
,
VLXXXX
,
VOXXXX
,
WAXXXX
,
WIXXXX
,
WNXXXX
,
XEXXXX
,
YAXXXX
,
YBXXXX
,
YFXXXX
Category(s):
Collaboration Sought > Collaboration
,
Application > Research Materials
,
Application > Diagnostics
,
Application > Vaccines
,
TherapeuticArea > Infectious Disease
,
Application > Consumer Products
,
Application > Therapeutics
Novel Rift Valley Fever Virus Vaccines
This invention relates to recombinant Rift Valley fever (RVF) viruses containing deletions in one or more virulence genes. The recombinant RVF viruses, generated using a plasmid-based reverse genetics system, can be used as vaccines to prevent RVF infection in livestock and humans. The recombinant RVF viruses grow to high titers, provide protective...
Published: 10/28/2024
|
Inventor(s):
Cesar Albarino
,
Stuart Nichol
,
Thomas Ksiazek
,
Brian Bird
Keywords(s):
Biodefense
,
bioterrorism
,
Bioterrorist
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
DB4BXX
,
DB4XXX
,
DC1XXX
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
DEVELOPING
,
DXXXXX
,
FEVER
,
Livestock
,
Method
,
methodology
,
Methods
,
Mosquito
,
Mosquitoes
,
OID-NCEZID-DHCPP
,
recombinant
,
Recombinant DNA
,
RIFT
,
rift valley
,
rift valley fever
,
rift valley fever virus
,
RVF
,
travel
,
traveler
,
travelers
,
tropical
,
Vaccine
,
Valley
,
VBXXXX
,
Vector
,
Vector
-based
,
Vector
-borne
,
Vector
-borne diseases
,
VETERINARY
,
VETERINARY vaccine
,
viral
,
virus
,
Viruses
,
VLXXXX
,
VOXXXX
,
WAXXXX
,
WIXXXX
,
WMXXXX
,
XEXXXX
,
XHXXXX
,
YBXXXX
,
YCXXXX
,
Zoo
,
Zoonotic
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics
,
Application > Vaccines
,
Application > Consumer Products
,
Application > Diagnostics
,
ResearchProducts > Research Equipment
,
Application > Research Materials
Diagnostics, Vaccines, and Delivery-Vehicles Related to Novel Phlebovirus
This CDC invention relates to primers and probes that specifically hybridize with Heartland virus (HRTLDV), a unique member of the genus Phlebovirus. It further relates to polyclonal antibodies specific for HRTLDV proteins. Serological detection assays using HRTLDV nucleic acid molecules, proteins, probes, primers, and antibodies are provided. Importantly,...
Published: 10/28/2024
|
Inventor(s):
Stuart Nichol
,
William Nicholson
,
Cynthia Goldsmith
,
Aubree Kelly
,
Laura McMullan
Keywords(s):
AC4XXX
,
ACXXXX
,
ANTIBODY
,
ANTIGEN
,
AXXXXX
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
Compositions
,
DA4BXX
,
DA4XXX
,
DAXXXX
,
DC1XXX
,
DC5BXX
,
DC5XXX
,
DCXXXX
,
DDXXXX
,
Delivery
,
delivery system
,
DEVELOPED
,
diagnostic
,
DXXXXX
,
GB2CXX
,
GB2XXX
,
GBXXXX
,
GCXXXX
,
GENE THERAPY
,
gene transfer
,
GXXXXX
,
heartland
,
heartland virus
,
Hospitalized
,
Identification
,
ISOLATES
,
Isolation
,
Methods
,
Missouri
,
Novel
,
PATHOGENIC
,
PHLEBOVIRUS
,
PLATFORM
,
Platforms
,
sequence
,
therapeutic
,
therapeutic candidates
,
THEREOF
,
TICK
,
TICK-BORNE
,
TICKS
,
TWO
,
Vaccine
,
VACCINE
VECTOR
S
,
Vector
,
Vector
-based
,
Vector
-borne
,
Vector
-borne diseases
,
VETERINARY
,
VETERINARY vaccine
,
viral
,
virus
,
VLXXXX
,
VOXXXX
,
WBXXXX
,
WDXXXX
,
WFXXXX
,
WIXXXX
,
WJXXXX
,
XAXXXX
,
XCXXXX
,
XHXXXX
,
YAXXXX
,
YBXXXX
,
Zoo
Category(s):
Collaboration Sought > Licensing
,
ResearchProducts > Antibodies
,
ResearchProducts > Research Equipment
,
Application > Research Materials
,
TherapeuticArea > Immunology
,
Application > Diagnostics
,
Application > Vaccines
,
Application > Therapeutics
,
TherapeuticArea > Infectious Disease
,
Application > Occupational Safety and Health
,
Application > Consumer Products
Novel Targets to Prevent Borrelia burgdorferi Infection and Lyme Disease
B. burgdorferi-infected ticks can cause Lyme disease in mammalian hosts. This technology relates to the use of B. burgdorferi outer surface proteins (BBA64 and BBA66) as Lyme disease vaccine candidates. In vivo animal studies demonstrate these outer surface proteins inhibit tick-to-host B. burgdorferi transmission. Presently, there is no vaccine approved...
Published: 4/8/2024
|
Inventor(s):
Robert Gilmore
Keywords(s):
BBA66
,
BORRELIA
,
BURGDORFERI
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
COMPONENT
,
DA3XXX
,
DAXXXX
,
DB3XXX
,
DBXXXX
,
DC4XXX
,
DXXXXX
,
Gene
,
Infectivity
,
MAMMALIAN
,
Necessary
,
PATHOGEN
,
TICK
,
TRANSMISSION
,
Vector
,
Via
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Therapeutics
,
Application > Vaccines
,
Application > Diagnostics
CDC Mosquito Trap for Control and Surveillance of Mosquitoes Including Carriers of Zika & Other Viruses
Mosquitoes are responsible for spreading many viruses that can make people sick, including dengue, Zika, chikungunya, yellow fever, and more. The Centers for Disease Control and Prevention's (CDC's) new autocidal gravid ovitrap (AGO) mosquito trap is an inexpensive, simple-to-assemble, and easy-to-maintain trap that targets female mosquitoes looking...
Published: 10/28/2024
|
Inventor(s):
Manuel Amador
,
Andrew Mackay
Keywords(s):
Aedes
,
Aegypti
,
AFXXXX
,
AUTOCIDAL
,
AXXXXX
,
CDC Docket Import
,
CDC Docket Import CDC Prosecuting
,
CONTROL
,
DENGUE
,
DENGUE FEVER
,
DEXXXX
,
DXXXXX
,
GRAVID
,
insect
,
Insecticides
,
Insects
,
Listed LPM Houze as of 4/15/2015
,
Malaria
,
MALARIAL
,
Mosquito
,
Mosquitoes
,
MXXXXX
,
NON-TOXIC
,
OID-NCEZID-DVBD
,
OVITRAP
,
Pest
,
PESTICIDE
,
PESTICIDES
,
Pests
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
Surveillance
,
Targeting
,
Tool
,
TRAP
,
TRAPPING
,
UB1XXX
,
Vector
,
Vector
-based
,
Vector
-borne
,
Vector
-borne diseases
,
VLXXXX
,
VOXXXX
,
VQXXXX
,
WDXXXX
,
WEST NILE
,
WEST NILE VIRUS
,
WFXXXX
,
XDXXXX
,
YFXXXX
,
Zika
,
Zoonotic
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Infectious Disease
,
Application > Consumer Products
,
Application > Medical Devices
,
Application > Non-Medical Devices
,
Application > Research Materials
,
Application > Diagnostics
,
TherapeuticArea > Rare / Neglected Diseases
,
Application > Occupational Safety and Health
,
Application > Therapeutics
Capsid-Free AAV
Vector
s for Gene Delivery and Their Use for Gene Therapy
The invention concerns novel capsid-free AAV
vector
s that can be used for gene delivery and gene therapy applications. The invention provides for a linear nucleic acid molecule comprising in this order: a first adeno-associated virus (AAV) inverted terminal repeat (ITR), a nucleotide sequence of interest, and a second AAV ITR, wherein said nucleic acid...
Published: 10/28/2024
|
Inventor(s):
Lina Li
,
Luis Garcia
,
Cyriaque Beley
,
Thomas Voit
,
Robert Kotin
Keywords(s):
AAV
,
Cell
,
Clonal
,
Containing
,
DNA
,
GB2AXX
,
Lines
,
Listed LPM Reichman as of 4/15/2015
,
Post LPM Assignment Set 20150420
,
Pre LPM working set 20150418
,
Rescueable
,
Sf9
,
STABLE
,
Vector
,
VPXXXX
,
WJXXXX
,
XEXXXX
,
YAXXXX
,
YBXXXX
Category(s):
Collaboration Sought > Licensing
,
TherapeuticArea > Dental
,
TherapeuticArea > Endocrinology
,
Application > Therapeutics
,
TherapeuticArea > Ophthalmology
,
TherapeuticArea > Oncology
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Infectious Disease
An In-Vitro Cell System Useful For Identification of RORgamma Antagonists
The retinoid-related orphan receptors alpha, beta and gamma (RORalpha, beta and gamma , also referred to as NR1F1, 2 and 3, respectively) comprise a distinct subfamily of nuclear receptors. Study of ROR-deficient mice has implicated RORs in the regulation of a number of biological processes and revealed potential roles for these proteins in several...
Published: 10/28/2024
|
Inventor(s):
Yukimasa Takeda
,
Anton Jetten
Keywords(s):
AC5XXX
,
ACXXXX
,
AXXXXX
,
Cell
,
Cells
,
CHO
,
Co-expressing
,
DEVELOPED
,
Expression
,
IDXXXX
,
IXXXXX
,
Reporter.
,
RORC
,
RORE5-Luciferase
,
RORgamma
,
RXXXXX
,
System
,
TET-ON
,
Vector
,
Vitro
Category(s):
Collaboration Sought > Collaboration
,
Application > Research Materials
,
Application > Diagnostics
,
Application > Therapeutics
1
2